Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

Bioasis Technologies (BTI.V) – Investor Roundtable

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, our focus is on Bioasis Technologies (BTI.V), a Canadian firm developing groundbreaking IP to help transport therapeutic drugs across the brain blood barrier.

Enjoy!

 

Related Posts

More on ,

Leave a Reply

Your email address will not be published. Required fields are marked *